| Document Type
|
:
|
BL
|
| Record Number
|
:
|
877762
|
| Main Entry
|
:
|
Kansal, Ruchin.
|
| Title & Author
|
:
|
Redefining Innovation : : Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry.
|
| Publication Statement
|
:
|
Milton :: Productivity Press,, 2018.
|
| Page. NO
|
:
|
1 online resource (229 pages)
|
| ISBN
|
:
|
0429015925
|
|
|
:
|
: 0429015933
|
|
|
:
|
: 042950697X
|
|
|
:
|
: 9780429015922
|
|
|
:
|
: 9780429015939
|
|
|
:
|
: 9780429506970
|
|
|
:
|
1138581046
|
|
|
:
|
9781138581043
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Cover; Half Title; Title Page; Copyright Page; Contents; Reviews; Setting the Context; Foreword; Preface; Acknowledgments; The 80-80 Rule; Section I: Redefining Innovation; 1. Rise of a Unicorn Industry; Unintended Consequences of Disconnected Choices; The Western Biopharmaceutical Industry Takes Shape; The Golden Era; A "Unicorn Industry" Is in Place; A Perspective on Global Differences in Reimbursement of Biopharmaceuticals; Endnotes; 2. The Unicorn Industry Loses Its Wings; Limited White Spaces for Traditional Product-Focused Innovation; Therapies versus Cures.
|
|
|
:
|
5. Next-Generation Unicorn IndustryEndnotes; Section II: Igniting Growth; 6. Applying "The 80-80 Rule"; 7. Setting Up for Success; Leadership Foresight and Courage to Invest; A New Breed of Leaders; Teaming the Right Talent; Reflections on the Experiment in Challenging the Status Quo; Endnote; 8. Finding White Spaces; Embrace the Need, Money Will Follow; Outside In First, Inside Out Next; Endnotes; 9. Developing New Ventures; Design for the End User, but Consider the Ecosystem; Keep It Modular; Keep It Simple; 10. Becoming Adept at Partnering.
|
|
|
:
|
Outcome and Value versus Safety and EfficacyTransition from Old to New Technology; Commoditization; Consumerism; New Disruptors; Evolution of the Regulatory Framework as a Source of Disruption; An Industry Perspective; The Future?; Endnotes; 3. An Experiment in Challenging the Status Quo; Challenging the Status Quo; Innovation Is Not a Choice; Endnotes; 4. Innovation Redefined; Redefining Innovation; Drive the Core, but Know It Is a Short-Term Game; Invest in Adjacent; It Is Easier to Execute; Experiment with Breakthrough to Define New Futures; Beyond Healthcare; Endnotes.
|
|
|
:
|
Partnerships That Span Development and CommercializationMaking Partnerships Work; 11. Afterword; Authors; Index.
|
| Subject
|
:
|
Biopharmaceutics.
|
| Subject
|
:
|
Organizational change.
|
| Subject
|
:
|
Pharmaceutical biotechnology.
|
| Subject
|
:
|
Pharmaceutical industry-- Technological innovations.
|
| Subject
|
:
|
Biopharmaceutics.
|
| Subject
|
:
|
BUSINESS ECONOMICS-- Industries-- General.
|
| Subject
|
:
|
Organizational change.
|
| Subject
|
:
|
Pharmaceutical biotechnology.
|
| Subject
|
:
|
Pharmaceutical industry-- Technological innovations.
|
| Subject
|
:
|
Drug Industry.
|
| Subject
|
:
|
Biopharmaceutics.
|
| Subject
|
:
|
Inventions.
|
| Subject
|
:
|
Organizational Innovation.
|
| Dewey Classification
|
:
|
338.476151
|
| LC Classification
|
:
|
RS380.K36 2018eb
|
| NLM classification
|
:
|
2018 F-543
|
|
|
:
|
QV 736.1
|
| Added Entry
|
:
|
Huth, Jeff.
|